Publicaciones en las que colabora con María Sanjurjo Sáez (21)

2023

  1. Appropriateness of Empirical Antibiotic Therapy for Cervicitis and Urethritis Prescribed in the Emergency Department

    Hospital Pharmacy, Vol. 58, Núm. 1, pp. 106-110

  2. Hacia la excelencia en la atención farmacéutica al paciente quirúrgico

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 47, Núm. 1, pp. 26-30

  3. Presence of metallic components in transdermal drug delivery systems and risk of skin burns

    Farmacia Hospitalaria

2022

  1. PCSK9 inhibitors revisited: Effectiveness and safety of PCSK9 inhibitors in a real-life Spanish cohort

    Biomedicine and Pharmacotherapy, Vol. 146

2021

  1. La importancia de los casos clínicos para la Farmacia Hospitalaria

    Revista Española de Casos Clínicos en Medicina Interna (RECCMI), Vol. 6, Núm. 2, pp. 1-1

2020

  1. Promoting clinical pharmacy services through advanced medication review in the emergency department

    European Journal of Hospital Pharmacy , Vol. 27, Núm. 2, pp. 73-77

2019

  1. Cancellations of elective surgical procedures due to inadequate management of chronic medications

    Journal of Clinical Pharmacy and Therapeutics, Vol. 44, Núm. 4, pp. 561-564

  2. Drug safety surveillance within a strategy for the management of non-chemotherapy drug-induced neutropenia

    International Journal of Clinical Pharmacy, Vol. 41, Núm. 5, pp. 1143-1147

  3. Thromboprophylaxis Management in Surgical Patients: The Efficacy of a Protocol in the Electronic Prescription Program

    Quality management in health care, Vol. 28, Núm. 4, pp. 245-249

2018

  1. Twelve weeks of ombitasvir/paritaprevir/r and dasabuvir without ribavirin is effective and safe in the treatment of patients with HCV genotype 1b infection and compensated cirrhosis: results from a real-world cohort study

    Expert Opinion on Drug Safety, Vol. 17, Núm. 3, pp. 235-241

2017

  1. Análisis de los resultados económicos y en salud de un programa dirigido a la reducción de hemorragia en pacientes con síndrome coronario agudo

    Revista Espanola de Cardiologia, Vol. 70, Núm. 10, pp. 825-831

2016

  1. Decreased INR after acenocoumarol, ombitasvir/paritaprevir/ritonavir and dasabuvir co-administration

    Journal of Clinical Pharmacy and Therapeutics, Vol. 41, Núm. 4, pp. 444-446

  2. Level of concordance between two risk-assessment models for predicting venous thromboembolism in medical patients at admission

    European Journal of Hospital Pharmacy , Vol. 23, Núm. 3, pp. 141-144

  3. Optimisation of antithrombotic therapy in patients with acute coronary syndrome to reduce bleeding episodes

    International Journal of Clinical Practice, Vol. 70, Núm. 2, pp. 156-162

  4. The challenges of the loading dose

    Drugs and Therapy Perspectives, Vol. 32, Núm. 10, pp. 447-448

2015

  1. Impact of the endorse study results on thromboprophylaxis prescribing patterns in medical patients attending the Emergency Department

    International Journal of Clinical Practice, Vol. 69, Núm. 1, pp. 81-86

  2. Implementation of smart pump technology in a paediatric intensive care unit

    Health Informatics Journal, Vol. 21, Núm. 3, pp. 209-222

  3. La clave de las tres ’a’: Alternar analgesia al alta

    Emergencias

2014

  1. Effectiveness of a pilot intervention to reduce abciximab-related bleeding in patients with acute coronary syndromes

    International Journal of Clinical Pharmacy, Vol. 36, Núm. 4, pp. 821-826

  2. Prevention and treatment of intraluminal catheter thrombosis in children hospitalised in a paediatric intensive care unit

    Journal of Paediatrics and Child Health, Vol. 50, Núm. 1, pp. 40-46